Parecoxib Approval Status
Parecoxib sodium is a non-narcotic injectable COX-2 selective analgesic for the treatment of acute pain.
In September 2005, Pfizer Inc. announced the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA), advising the company that the New Drug Application (NDA) for parecoxib had not been approved.
Development Status and FDA Approval Process for Parecoxib
|Sep 20, 2005||Pfizer Receives FDA Non-Approvable Letter on Parecoxib|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.